357 related articles for article (PubMed ID: 1079030)
1. Cell-mediated immunity in acute and chronic hepatitis.
Wands JR; Perrotto JL; Alpert E; Isselbacher KJ
J Clin Invest; 1975 May; 55(5):921-9. PubMed ID: 1079030
[TBL] [Abstract][Full Text] [Related]
2. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.
Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA
J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716
[TBL] [Abstract][Full Text] [Related]
3. Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH).
Warnatz H; Rösch W; Gerlich W; Gutmann W
Clin Exp Immunol; 1979 Jan; 35(1):133-40. PubMed ID: 371882
[TBL] [Abstract][Full Text] [Related]
4. Alteration in cell-mediated immunity in patients with chronic active hepatitis. I. Lymphocyte subpopulations.
Ponzetto A; Arrigoni A
G Batteriol Virol Immunol; 1979; 72(1-6):28-32. PubMed ID: 317950
[TBL] [Abstract][Full Text] [Related]
5. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.
Eggink HF; Houthoff HJ; Huitema S; Wolters G; Poppema S; Gips CH
Clin Exp Immunol; 1984 Apr; 56(1):121-8. PubMed ID: 6713726
[TBL] [Abstract][Full Text] [Related]
6. Disordered immunoregulatory functions in patients with chronic active hepatitis.
Nonomura A; Tanino M; Kurumaya H; Ohta G; Kato Y; Kobayashi K
Clin Exp Immunol; 1982 Mar; 47(3):595-605. PubMed ID: 6211306
[TBL] [Abstract][Full Text] [Related]
7. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes.
Mondelli M; Vergani GM; Alberti A; Vergani D; Portmann B; Eddleston AL; Williams R
J Immunol; 1982 Dec; 129(6):2773-8. PubMed ID: 6982941
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of lymphocyte cytotoxicity in chronic active hepatitis.
Kakumu S; Hara T; Gohji H; Sakamoto N
Clin Exp Immunol; 1978 Jul; 33(1):71-8. PubMed ID: 709913
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections.
Chisari FV; Routenberg JA; Edgington TS
J Clin Invest; 1976 May; 57(5):1227-38. PubMed ID: 1083396
[TBL] [Abstract][Full Text] [Related]
10. The effector cells in human peripheral blood mediating mitogen-induced cellular cytotoxicity and antibody-dependent cellular cytotoxicity.
Nelson DL; Bundy BM; Pitchon HE; Blaese RM; Strober W
J Immunol; 1976 Nov; 117(5 Pt 1):1472-81. PubMed ID: 1087314
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis.
Vergani GM; Vergani D; Jenkins PJ; Portmann B; Mowat AP; Eddleston AL; Williams R
Clin Exp Immunol; 1979 Oct; 38(1):16-21. PubMed ID: 393438
[TBL] [Abstract][Full Text] [Related]
12. In vitro study of IgG production and concanavalin A induced suppressor cell function in acute and chronic hepatitis B virus infection.
Nouri-Aria KT; Alexander GJ; Portmann B; Vergani D; Eddleston AL; Williams R
Clin Exp Immunol; 1986 Apr; 64(1):50-8. PubMed ID: 2942323
[TBL] [Abstract][Full Text] [Related]
13. Antibody dependent cellular cytotoxicity (ADCC) in acute hepatitis B and in chronic active hepatitis.
Bortolotti F; Realdi G; Diodati G; Fattovich G
Clin Exp Immunol; 1978 Aug; 33(2):211-6. PubMed ID: 719950
[TBL] [Abstract][Full Text] [Related]
14. Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum.
Newberry WM; Sanford JP
J Clin Invest; 1971 Jun; 50(6):1262-71. PubMed ID: 5578233
[TBL] [Abstract][Full Text] [Related]
15. Diminished active T rosette levels and increased spontaneous B lymphocyte blastogenesis in hepatitis B virus positive chronic active hepatitis.
Budillon G; Scala G; D'Onofrio C; Cassano S; De Ritis F
Clin Exp Immunol; 1983 Jun; 52(3):472-6. PubMed ID: 6603293
[TBL] [Abstract][Full Text] [Related]
16. Immunological studies on chronic active hepatitis: possible involvement of macrophage-mediated cytotoxicity in its immunopathogenesis.
Mizoguchi Y; Shiba T; Ohnishi F; Monna T; Yamamoto S; Morisawa S
Hepatogastroenterology; 1981 Oct; 28(5):250-3. PubMed ID: 7047338
[TBL] [Abstract][Full Text] [Related]
17. Selective expansion of cytotoxic T lymphocytes with a CD4+CD56+ surface phenotype and a T helper type 1 profile of cytokine secretion in the liver of patients chronically infected with Hepatitis B virus.
Barnaba V; Franco A; Paroli M; Benvenuto R; De Petrillo G; Burgio VL; Santilio I; Balsano C; Bonavita MS; Cappelli G
J Immunol; 1994 Mar; 152(6):3074-87. PubMed ID: 7511637
[TBL] [Abstract][Full Text] [Related]
18. Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.
Eggink HF; Houthoff HJ; Huitema S; Gips CH; Poppema S
Clin Exp Immunol; 1982 Oct; 50(1):17-24. PubMed ID: 6983407
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of peripheral blood lymphocytes in chronic HBsAg carriers.
Alexander GJ; Mondelli M; Naumov NV; Nouriaria KT; Vergani D; Lowe D; Eddleston AL; Williams R
Clin Exp Immunol; 1986 Mar; 63(3):498-507. PubMed ID: 2940037
[TBL] [Abstract][Full Text] [Related]
20. Suppressor cell activity in viral and non-viral chronic active hepatitis.
Tremolada F; Fattovich G; Panebianco G; Ongaro G; Realdi G
Clin Exp Immunol; 1980 Apr; 40(1):89-95. PubMed ID: 6446433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
